After participating in these interactive patient case studies, the learner will be able to:
- Select the most appropriate treatment approach for newly diagnosed metastatic PDAC based on patient and disease characteristics
- Identify optimal treatment strategies for patients with progressive PDAC (second line therapy and beyond)
- Describe the current and potential use of biomarkers in PDAC
These two case studies are intended for global medical, surgical and radiation oncologists, gastroenterologists, and other healthcare providers involved in the management of patients with pancreatic cancer, and any other clinicians involved in the diagnosis, treatment and follow-up of patients with PDAC.
Developed with an independent educational grant from Shire and supported by Servier.
Produced by Springer Healthcare IME.
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK